Licensed Practical Nurse in Richmond Hts, OH Accepting Medicare

7 Licensed Practical Nurse nurses found. Showing 1 - 7

Verenda Deon Evans, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 180 Brush Rd, Richmond Hts, OH 44143 Phone: 216-376-2495

Joyce Niba, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 440 Richmond Park East C601, Richmond Hts, OH 44143 Phone: 216-835-0709

Vanessa Nicole Sarubbi, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 425 Harris Rd, Richmond Hts, OH 44143 Phone: 216-482-5606

Rachael M Hawkins, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 26670 Loganberry Dr Apt A116, Richmond Hts, OH 44143 Phone: 216-324-2205

Mrs. Rose Mabrey, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4791 Geraldine Rd, Richmond Hts, OH 44143 Phone: 216-297-0793    Fax: 216-297-0793

Mrs. Zakiyyah H Andrews, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 135 Chestnut Ln, J411, Richmond Hts, OH 44143 Phone: 216-731-7312    Fax: 216-731-7312

Miss Lenette M Wilder, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 120 Ruth Ellen Dr, Apt 217, Richmond Hts, OH 44143 Phone: 216-694-0469

News Archive

Illumina begins to ship HumanOmni5-Quad DNA Analysis BeadChip

Illumina, Inc. today announced that it has begun shipping the HumanOmni5-Quad DNA Analysis BeadChip (Omni5), the new flagship array of the Omni family of microarrays.

Researchers to examine risks and benefits of blood transfusions

Risks associated with blood transfusions are to be scrutinized in a new national project that will inform public policy on the process.

Study reveals new insight into Fuchs' endothelial corneal dystrophy

The molecular changes that lead to Fuchs' endothelial corneal dystrophy (FECD) occur decades before the disease causes blurry vision and other noticeable symptoms in patients, new research by UT Southwestern scientists shows.

Millennium, Seattle Genetics' new brentuximab vedotin trial data presented at ASCO 2011

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today reported updated data from a pivotal trial of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and a phase II trial in relapsed or refractory systemic anaplastic large cell lymphoma.

Read more Medical News

› Verified 2 days ago